Vimarsana
Biggest News Aggregation in the World

Page 11 - Ace2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ace2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ace2 Today - Breaking & Trending Today

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential - Vimarsana News

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

Researchers demonstrated the inhalation of an ACE2 decoy receptor, sACE22.v2.4-IgG1, increases survival and ameliorates lung injury in K18-hACE2 transgenic mice.

Model for investigating the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex - Vimarsana News

Model for investigating the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex

Researchers used a CNN regression model to investigate the effect of mutations on the binding affinity of the SARS-CoV-2 RBD-ACE2 complex.

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction - Vimarsana News

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A new study has focussed on screening and identification of possible SMIs of this PPI for COVID-19.

Researchers investigate Galectin-9 as a new treatment target for COVID-19 - Vimarsana News

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers discuss alternate therapeutic targets for treating COVID-19 and the effects of Gal-9 on SARS-CoV-2 infection and the immune response.

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve - Vimarsana News

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

The National Institute of Health awarded $436,642 to associate professor of biomedical engineering, Kartik Balachandran, to study the downstream effects of acute respiratory syndrome coronavirus 2 on the aortic valve.